Sign in
James Walker

James Walker

Chief Executive Officer at Nano Nuclear Energy
CEO
Executive
Board

About James Walker

James Walker (age 42) is Chief Executive Officer, Head of Reactor Development, and a director at Nano Nuclear Energy (NNE) since 2022, with 17+ years of engineering project management experience across construction, mechanical, and nuclear engineering domains . He holds a B.Eng. in Mechanical Engineering (University of Nottingham), M.Sc. in Mining Engineering (University of Exeter), and M.Sc. in Nuclear Engineering (Cranfield University); he is a Chartered Engineer (IMechE, 2014), Chartered Physicist (IoP, 2023), P.Eng. (Canada, 2023), and APM-qualified project manager . In FY2023–FY2024, NNE did not report salary/bonus or non-equity incentive payouts for Walker (compensation was via consulting fees); no TSR/revenue/EBITDA performance linkage was disclosed for his pay in those years .

Past Roles

OrganizationRoleYearsStrategic impact
UK Ministry of DefenceMechanical/Nuclear Engineer; later Engineering Project ManagerPre-2013; 2013–2016Led infrastructure and nuclear lifecycle projects; project lead for nuclear material reclamation plant; engineering manager for reactor core manufacturing facilities .
Rolls-Royce (secondment)Nuclear Physicist (Zero-Power reactor modeling)2012–2013Led probabilistic physics modeling to replicate reactor behavior and establish accuracy margins .
Lithium Energy ProductsHead of Company Strategy2016–2020Oversaw projects, resource allocation, grants, and collaborations in lithium exploration .
Ares Strategic Mining (CNSX:ARS)Senior Executive Manager2020–presentResponsible for plant construction, land purchases, operations, marketing, financing, safety, and shareholder relations .

External Roles

OrganizationRoleYearsNotes / governance implications
Bayhorse Silver Inc. (TSXV: BHS)DirectorNot disclosed (current)Small-cap Canadian public company directorship .
Xander Resources Inc. (TSXV: XND)DirectorNot disclosed (current)Small-cap Canadian public company directorship .
LIS Technologies Inc. (LIST, private)ConsultantNot disclosed (current)LIST is a related party to NNE through common management and ownership; NNE invested $2.0M in LIST and entered collaborations/leases; Walker’s LIST role is a related-party linkage to monitor .
Ares Strategic Mining (CNSX: ARS)Senior executive manager2020–presentConcurrent executive role alongside NNE CEO; time/attention balance should be monitored .

Fixed Compensation

Note: NNE’s NEOs (including Walker) served as consultants in FY2023–FY2024 (not employees). “All Other Compensation” reflects consulting fees; Salary/Bonus were not paid; no non-equity incentives were paid .

Metric (USD)FY 2023FY 2024
Salary
Bonus
Option Awards (grant-date fair value)$317,652
Non-Equity Incentive Plan Compensation
All Other Compensation (consulting fees)$90,000 $185,000
Total$407,652 $185,000

Additional disclosure:

  • NNE incurred consulting fees to Walker of $90,000 (FY2023) and $185,000 (FY2024), recorded in G&A .

Performance Compensation

There were no disclosed annual performance metrics (e.g., revenue/EBITDA/TSR) tied to Walker’s pay in FY2023–FY2024; non‑equity incentive pay was not awarded . Equity awards were stock options granted in 2023 that fully vested at grant (no performance vesting) .

  • Equity awards detail (options): | Grant date | Vesting | Options exercisable | Exercise price | Expiration | |---|---|---:|---:|---| | Feb 10, 2023 | Immediate (fully vested at grant) | 500,000 | $1.50 | Feb 10, 2026 | | Jun 7, 2023 | Immediate (fully vested at grant) | 200,000 | $3.00 | Jun 7, 2026 |

  • Plan features affecting incentives: 2025 Equity Incentive Plan (pending/approved at 2025 meeting) includes stockholder‑friendly provisions (no repricing without stockholder approval, non‑employee director cash/equity caps, robust clawback language) . Company defines Clawback Policies to align with Dodd‑Frank/SOX/listing standards .

Equity Ownership & Alignment

ItemAmount
Direct shares owned300,000 shares
Exercisable options (within 60 days of Record Date)700,000 options
Total beneficial ownership1,000,000 shares (incl. options)
% of shares outstanding2.65% (based on 37,072,881 shares outstanding at Record Date)
Shares outstanding at Record Date37,072,881

Additional alignment/controls:

  • Options are non-transferable; awards under 2023 plans may not be assigned, pledged, or transferred (except by will/descent) . The proxy does not disclose any pledging of NNE common shares by Walker .
  • No retirement benefit arrangements for NEOs were sponsored at this time .
  • Amounts due to related parties included unpaid compensation owed to Walker: $30,000 (as of Sep 30, 2023) and $25,000 (as of Sep 30, 2024) .

Employment Terms

  • Status/term: Walker and other NEOs served under consulting agreements (36‑month terms from effective dates, subject to early termination) with retention fees and eligibility for discretionary additional awards; restrictive covenants include confidentiality, customer and employee non‑solicitation, and non‑disparagement .
  • Severance/COC: No specific severance or change‑in‑control benefits disclosed for Walker (contrast: separate employment agreement and severance terms are disclosed for President/Chairman Jay Jiang Yu) .
  • Clawback/insider trading: Company adopted an Amended and Restated Insider Trading Policy in Dec 2024; 2025 Plan contains robust clawback language; “Clawback Policies” defined to comply with applicable laws/listing standards .

Board Governance

  • Role: CEO and director (not independent) . Executive directors receive no compensation for director service (director pay applies only to non‑executives) .
  • Committee structure: Audit, Compensation, and Nominating & Corporate Governance Committees are composed solely of independent directors (Drs. Kenny Yu, Tsun Yee Law, and Ms. Diane Hare). Chairs: Audit—Dr. Tsun Yee Law; Compensation—Dr. Tsun Yee Law; Nominating & Corporate Governance—Ms. Diane Hare .
  • Independence practices: Board determined three independent directors; independent directors meet in executive sessions (only independents present) .
  • Dual‑role implications: Walker is CEO and director but not Chair (Chair is President Jay Jiang Yu); key committees are independent, mitigating CEO/board independence concerns .

Director Compensation (context)

  • Independent directors received cash fees (e.g., FY2024: $25,000 Law; $35,000 Hare; $35,000 Kenny Yu) and previously were granted options (fully vested at grant; 30–40k per director in 2023) . Executive directors (including Walker) do not receive director compensation .

Related-Party Transactions (governance risk indicators)

  • LIST relationship: In Aug 2024, NNE invested $2.0M in LIS Technologies (LIST), entered collaboration to secure enriched UF6 supply with profit‑sharing to be agreed, and leased ~7,000 sq ft at $7,000/month (Sep 2, 2024–Sep 1, 2034). Relationship is related‑party: Walker is a consultant to LIST; certain NNE executives/directors also serve at LIST. Investment approved unanimously by disinterested independent directors .
  • Amounts due to related parties: $25,000 payable to Walker at FY2024‑end; $30,000 at FY2023‑end .

Performance & Track Record (selected operational highlights)

  • Strategic acquisition: On Jan 10, 2025, NNE closed the acquisition of select Ultra Safe Nuclear Corporation assets (including MMR/transportable reactor tech) via a court‑approved Section 363 process for $8.5M cash; Canadian components subject to separate consents/option structure with the founder; this expands reactor development platforms under Walker’s remit as CEO/Head of Reactor Development .

Compensation Structure Analysis

  • Cash vs equity mix shift: 2023 included a material option grant ($317,652 grant‑date fair value), while 2024 had no new equity awards; cash consulting fees rose from $90,000 (2023) to $185,000 (2024) .
  • Risk of time‑based equity: 2023 options were fully vested at grant (no performance metrics), reducing direct pay‑for‑performance alignment; both tranches expire in 2026, which can increase exercise timing considerations as expiration approaches .
  • Governance enhancements: 2025 Equity Plan proposes anti‑repricing, director pay limits, and robust clawback language; company formalized an updated insider trading policy in Dec 2024 .

Equity Awards, Vesting, and Potential Selling Pressure

  • Immediate vesting on both 2023 grants; options are non‑transferable/ non‑pledgeable under the plan terms; expirations in Feb and Jun 2026 create a finite window to exercise (monitor potential Form 4 activity as expirations near) .

Employment Terms Summary

TermDetails
Agreement typeConsulting agreement (36‑month term from effective date; early termination permitted) .
Restrictive covenantsConfidentiality; customer and employee non‑solicitation; non‑disparagement .
Severance/COCNot disclosed for Walker; no employment agreement disclosed as of FY2024 .
Retirement benefitsNone sponsored for NEOs at this time .
Clawback/insider tradingAmended Insider Trading Policy (Dec 2024); 2025 Plan includes robust clawback language; “Clawback Policies” defined .

Investment Implications

  • Alignment: Walker holds 2.65% beneficial ownership (1.0M incl. 700k options), a meaningful stake that aligns with shareholders; however, 2023 equity awards were fully vested at grant (no performance linkage), and 2024 compensation was predominantly cash consulting fees, tempering near‑term pay‑for‑performance alignment .
  • Overhang/expiration dynamics: Two option grants (500k@$1.50; 200k@$3.00) expire in 2026; monitor exercise timing and any potential secondary liquidity effects as expirations approach .
  • Governance: CEO also serves as director but not Chair; independence preserved through fully independent Audit/Compensation/Nominating committees and independent‑only sessions; executive directors receive no director fees, limiting double‑pay concerns .
  • Related‑party and execution risk: LIST ties (Walker consultant; NNE investor/lessor) and amounts due to officer indicate areas to monitor for conflicts and cash discipline; the USNC asset acquisition expands the reactor platform but entails integration and regulatory execution risk .